Top Markets
#1 Palladium Network Palladium Network +27.89%
#2 Ankr Network Ankr Network +10.42%
#3 would would +6.86%
#4 Hive Hive +6.25%
#5 WAX WAX +5.69%
#6 Pons Pons +4.94%
#7 The Bitcoin Bull The Bitcoin Bull +4.43%
#8 OpenAI (Republic Pre-IPO) OpenAI (Republic Pre-IPO) +4.16%
#9 edgeX edgeX +3.72%
#10 Ribbita by Virtuals Ribbita by Virtuals +3.31%
Coin of the day
Palladium Network Palladium Network
Pengaturan
Bahasa
BAHASA INDONESIA
Mata uang
USD
Tema
Nevro Corp. Nevro Corp.

Nevro Corp.

NVRO
Peringkat dalam Saham #17833
Nevro Corp. is a medical technology firm that delivers solutions for... Nevro Corp. is a medical technology firm that delivers solutions for individuals experiencing persistent pain, serving markets both domestically in the United States and across the globe. The company's core business involves the development and market introduction of the Senza spinal cord stimulation (SCS) system, an advanced, clinically supported neuromodulation platform specifically engineered to alleviate chronic pain. This portfolio encompasses its newer generations, the Senza II and Senza Omnia systems. Additionally, Nevro offers its proprietary 10 kHz Therapy, providing neuromodulation approaches grounded in robust clinical evidence for effective chronic pain management. Its products are distributed through a diverse strategy, utilizing a dedicated direct sales team complemented by a network of specialized sales agents and independent distributors. Founded in 2006, Nevro Corp. maintains its corporate headquarters in Redwood City, California.
Harga Saham
$5.84
Terakhir disinkronkan: 2025-04-02
Kapitalisasi Pasar
$224.09M
Perubahan (1 hari)
0.00%
Perubahan (1 tahun)
0.00%
Negara
US
Perdagangan Nevro Corp. (NVRO)

Kategori

Healthcare
Laba untuk Nevro Corp. (NVRO)
Laba pada Dec 2024 TTM: $-112.35M
Menurut laporan keuangan terbaru dari Nevro Corp., laba saat ini perusahaan adalah $-112.35M. Pada tahun 2023, perusahaan memperoleh laba sebesar $-97.86M, penurunan dibandingkan dengan laba tahun 2022 sebesar $4.26M. Laba yang ditampilkan di halaman ini adalah laba sebelum bunga dan pajak, atau disebut juga EBIT.
Riwayat laba untuk Nevro Corp. dari 2012 hingga 2026
Laba pada akhir setiap tahun
Tahun Laba Mengubah
2026 (TTM) $-112.35M 0.00%
2024 $-112.35M 14.80%
2023 $-97.86M -2,395.00%
2022 $4.26M -103.26%
2021 $-130.83M 59.16%
2020 $-82.20M -19.48%
2019 $-102.09M 110.76%
2018 $-48.44M 37.41%
2017 $-35.25M 16.90%
2016 $-30.16M -54.49%
2015 $-66.27M 119.41%
2014 $-30.20M 17.74%
2013 $-25.65M 36.41%
2012 $-18.81M 0.00%
Laba untuk perusahaan serupa atau pesaing
Perusahaan Laba Perbedaan Laba Negara
Abbott Laboratories Abbott Laboratories
Abbott Laboratories
ABT.US
$7.51B -6,785.60%
US
Stryker Corporation Stryker Corporation
Stryker Corporation
SYK.US
$5.15B -4,682.27%
US
Medtronic plc Medtronic plc
Medtronic plc
MDT.US
$5.56B -5,051.67%
IE
Boston Scientific Corporation Boston Scientific Corporation
Boston Scientific Corporation
BSX.US
$3.86B -3,536.70%
US
Edwards Lifesciences Corporation Edwards Lifesciences Corporation
Edwards Lifesciences Corporation
EW.US
$1.42B -1,361.82%
US